CBT Pharmaceuticals Secures $9,750,000 Series A Financing

  • Feed Type
  • Date
    8/31/2016
  • Company Name
    CBT Pharmaceuticals
  • Mailing Address
    3375 Scott Blvd. Santa Clara, CA 95054 USA
  • Company Description
    CBT Pharmaceuticals is an emerging life sciences oncology company focused on developing innovative medicines targeting the growth and proliferation of cancer cells for which available treatments are inadequate.
  • Website
    http://www.cbtpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $9,750,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    This financing allows us to advance two of our four development programs into human clinical trials.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    Undisclosed

Trending on Xconomy